Volume | 27 057 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 3,27 | Bas Haut |
|||||
Minimum Bas | 3,1014 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
MyMD Pharmaceuticals Inc | MYMD | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
3,27 | 3,1014 | 3,27 | 3,20 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
231 | 27 057 | US$ 3,18 | US$ 86 164 | - | 2,00 - 70,50 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
21:38:13 | 24 | US$ 3,23 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
6,74M | 2,09M | - | 0 | -8,22M | -3,93 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action MyMD Pharmaceuticals
Date | Heure | Source | Titre |
---|---|---|---|
07/3/2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
05/3/2024 | 17:00 | Edgar (US Regulatory) | Form 8-K - Current report |
05/3/2024 | 15:15 | Business Wire | MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum.. |
14/2/2024 | 21:13 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
14/2/2024 | 17:27 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
13/2/2024 | 22:57 | Edgar (US Regulatory) | Form 8-K - Current report |
13/2/2024 | 17:45 | Business Wire | MyMD Pharmaceuticals Announces Reverse Stock Split to.. |
06/12/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
06/12/2023 | 15:15 | Business Wire | MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical.. |
19/10/2023 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
19/10/2023 | 15:00 | Business Wire | MyMD Announces Preclinical Study Results Showing Novel.. |
13/10/2023 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action MyMD Pharmaceuticals
Aucune Discussion TrouvéeAjouter une Discussion
Historiques MyMD Pharmaceuticals Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 2,82 | 3,36 | 2,74 | 3,07 | 59 466 | 0,4174 | 14,80% |
1 mois | 2,25 | 3,50 | 2,00 | 2,62 | 629 119 | 0,9874 | 43,88% |
3 mois | 3,999 | 4,50 | 2,00 | 3,08 | 354 587 | -0,7616 | -19,04% |
6 mois | 11,40 | 12,0615 | 2,00 | 6,56 | 971 987 | -8,16 | -71,60% |
1 an | 58,50 | 70,50 | 2,00 | 18,24 | 813 295 | -55,26 | -94,47% |
3 ans | 128,70 | 298,50 | 2,00 | 52,40 | 420 135 | -125,46 | -97,48% |
5 ans | 162,90 | 298,50 | 2,00 | 57,44 | 438 626 | -159,66 | -98,01% |